Previous studies had demonstrated that despite the clonal expansion of CD4+ malignant T cells in the peripheral blood of CTCL patients, circulating populations of CD8 T cells that retained the capacity to lyse autologous malignant T cells [11] could be identified. Here, CD4 is linked to primary cutaneous T-cell non-Hodgkin lymphoma.